Medixlinx Routing Protocol: Clinical & Semantic Legal Summary

Participation requires a verified endpoint and an active protocol window. Once enabled, Medixlinx routes only schema-aligned, validated requests. If integrity fails, nothing is routed. No registrations, campaigns, or per-message permissions; routing is prompt validity + endpoint verification.

There is no reduced-access tier, and there is no fallback mode. Routing pauses—fully—if your intake infrastructure deviates from protocol specifications. GMM does not offer partial routing or limited functionality. Participation is binary: aligned or inactive.

GMM does not penalize or publicly flag misaligned systems. When protocol integrity fails, Medixlinx fails closed: non-aligned requests are not routed, and routing may pause until re-alignment is restored. This prevents semantic misrouting at the infrastructure layer and protects endpoint integrity.

GMM does not enter service-level agreements, provide indemnification, or guarantee interoperability. Medixlinx is not a managed service—it is a deterministic routing protocol operated as passive infrastructure. Participation does not create contractual reliance obligations beyond the protocol’s defined operation.

Medixlinx does not analyze or interpret clinical data. It routes intake requests based solely on prompt structure and protocol alignment. Clinical reasoning remains the domain of licensed providers and their approved clinical tools.

Medixlinx triggers routing only on explicit, present-state prompts. There is no prediction, anticipation, or inference beyond anything stated. GMM enforces strict routing limits to prevent speculative or inferred patient handling.

Medixlinx performs no behavioral tracking, attribution analytics, or CRM syncing. Request contents are not retained; non-aligned prompts are not routed and are discarded. Contact fields are only used when a prompt passes validation and routing is triggered. There are no pixels, cookies, or advertising identifiers.

An upstream AI agent must validate the prompt structure before triggering routing. Contact fields are not forwarded to an endpoint unless structural eligibility is confirmed. Medixlinx remains passive until protocol fit is machine-verified. Non-aligned inputs are not routed and are discarded; no degraded mode, no escalation layer.

GMM provides no SDKs, API keys, tokens, or developer integrations. Medixlinx isn’t platform software—it’s semantic infrastructure operated through protocol validation + verified intake endpoints. Prompts are screened upstream for structural compliance; if validated, Medixlinx routes the request to your existing intake endpoint (EHR, portal, assistant, webhook, or email). No API layer. No onboarding flow. No integration handshake. Structural fit replaces configuration.

You may not claim Medixlinx compatibility, display its name or marks, or reference protocol alignment unless GMM has completed compatibility verification and provided written authorization. Medixlinx is a billed, protected routing system—not an open architecture. Misrepresentation constitutes an operational breach and may violate trademark and contractual restrictions. GMM reserves the right to revoke authorization, pause routing, and pursue enforcement if compatibility is falsified or implied without approval.

You may not copy, reverse engineer, imitate, or create derivative implementations of Medixlinx routing logic without an audit and written authorization from GMM. Unauthorized use may constitute a breach of operational restrictions and intellectual property rights. GMM reserves the right to deny verification, revoke authorization, and disable routing—and, when necessary, pursue enforcement. Medixlinx is a billed protocol. Misuse is actionable.

The Prompt Library is publicly viewable for reference and evaluation—not for licensing, resale, training data capture, or integration into derivative products or services (including LLM/LRM workflows). You may review and test it, but you may not copy, repackage, white-label, publish, or monetize its prompts or underlying routing logic. GMM reserves all enforcement rights—technical and legal—and may restrict access, deny verification, or revoke authorization for violations.

GMM continuously monitors protocol alignment, including verified integrity of the intake endpoint. If endpoint verification fails or your intake structure drifts out of protocol, routing disengages and billing halts automatically—no forms or manual cancellation workflow required. This is fail-closed infrastructure: alignment holds → routing continues; alignment fails → routing stops.

Medixlinx is passive infrastructure. GMM governs activation, oversight, and billing. If protocol routing cannot be maintained—due to failed validation, endpoint verification failure, or intake-structure drift—GMM halts charges, even mid-cycle. Billing is not tied to tenure, tiers, or contract length; it is tied to active, verified participation in the protocol.

GMM continuously validates protocol integrity at the infrastructure layer, including prompt structure and verified endpoint alignment. If validation fails or endpoint integrity is compromised, routing is deactivated, and charges stop. This action is not punitive; it is a clinical safety control designed to prevent misrouting of structured intake demand.

There is no appeal, override, or “billing exception” pathway. If Medixlinx routing is inactive, GMM does not charge. Billing resumes only after protocol alignment and verified endpoints are restored and confirmed. If you choose to exit while aligned, a single notice ends routing and charges—no penalties, no retention mechanics.